Aster DM Quality Care Limited held its 18th Annual General Meeting on September 28, 2026, via Video Conferencing. The meeting adopted the audited standalone and consolidated financial statements for FY26 and approved the reappointment of director T J Wilson.

The company, formerly known as Aster DM Healthcare Limited, conducted the proceedings from its registered office in Hyderabad. Executive Chairman Dr Azad Moopen delivered the welcome address, while Executive Director Alisha Moopen chaired the session. The Board presented operational, financial, strategic, ESG, and CSR highlights for the fiscal year ended March 31, 2026.

Resolutions passed

Shareholders transacted both ordinary and special business items outlined in the notice dated August 5, 2026. The key resolutions included:

The auditor’s report did not contain any qualifications or adverse observations affecting the company’s functioning. Statutory registers were available for inspection during the meeting.

Attendance and voting

A total of 83 members attended the virtual meeting. Remote e-voting was open from September 25 to September 27, 2026. Members participating live could cast votes through the NSDL portal during the session. The scrutinizer’s report on the voting outcomes will be disseminated to stock exchanges separately in compliance with SEBI Listing Regulations.

Directors Ganesh Mani, Ayshwarya Vikram, and Sunil Theckath Vasudevan were absent due to prior commitments. The meeting concluded at 1:26 pm after a question-and-answer session addressed shareholder queries thematically by board members.

Aster DM Quality Care Limited shareholders approved all ten resolutions proposed in the postal ballot concluded on September 25, 2026. The approvals include the appointment of Varun Shadilal Khanna as Managing Director and Group CEO, along with a new Employee Stock Option Scheme for 2026.

The voting results were disclosed to the stock exchanges on September 26, 2026, under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The scrutinizer’s report confirmed that the requisite majority was secured for both ordinary and special resolutions.

Key Appointments Approved

The most significant governance changes involve leadership restructuring and board composition. Shareholders ratified the appointment of Varun Shadilal Khanna as Managing Director and Group Chief Executive Officer. Additionally, three non-executive directors were appointed to the board:

• Ayshwarya Ravi Vikram as Non-Executive Non-Independent Director
• Ganesh Mani as Non-Executive Non-Independent Director
• Neeraj Jain, Kewal Kundanlal Handa, and Valayil Korath Mathews as Non-Executive Independent Directors

The board also approved revisions to managerial remuneration for Executive Chairman Dr. Mandayapurath Azad Moopen and Ms. Alisha Moopen, who was redesignated as Executive Director.

Voting Results Breakdown

While all resolutions passed, the margin of support varied significantly across categories. The promoter group voted unanimously in favor of all items. Public institutional investors showed notable dissent on compensation and equity-linked schemes, while retail investors largely supported management proposals.

What the Numbers Show

A distinct divergence exists between retail and institutional voting patterns regarding equity incentives. While public non-institutional shareholders supported the new Employee Stock Option Scheme (ESOP) with 99.97% in favor, public institutional investors cast 34.69% of their votes against the same resolution. This resulted in an overall opposition rate of 11.25% for the ESOP scheme, significantly higher than the sub-1% opposition seen for director appointments. Similarly, the resolution regarding Alisha Moopen’s designation saw 15.82% institutional opposition, contrasting sharply with near-unanimous retail support.